High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance.
Cortés-López M, Schulz L, Enculescu M, Paret C, Spiekermann B, Quesnel-Vallières M, Torres-Diz M, Unic S, Busch A, Orekhova A, Kuban M, Mesitov M, Mulorz MM, Shraim R, Kielisch F, Faber J, Barash Y, Thomas-Tikhonenko A, Zarnack K, Legewie S, König J.
Cortés-López M, et al. Among authors: quesnel vallieres m.
Nat Commun. 2022 Sep 22;13(1):5570. doi: 10.1038/s41467-022-31818-y.
Nat Commun. 2022.
PMID: 36138008
Free PMC article.